本页面由Tiger Trade Technology Pte. Ltd.提供服务

enVVeno Medical Corp.

7.80
-0.3500-4.29%
成交量:5,633
成交额:4.47万
市值:541.94万
市盈率:-0.31
高:8.16
开:8.16
低:7.80
收:8.15
52周最高:28.70
52周最低:7.01
股本:69.48万
流通股本:60.25万
量比:1.40
换手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-24.8994
每股收益(LYR):-33.0600
净资产收益率:-58.53%
总资产收益率:-36.67%
市净率:0.26
市盈率(LYR):-0.24

数据加载中...

2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

重要事件披露

Form 8-K - Current report
2023/11/16

重要事件披露

Form 8-K - Current report
2023/11/02

SEC问询函

Form CORRESP - Correspondence
2023/10/26

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/12

重要事件披露

Form 8-K - Current report
2023/08/22

SEC问询函

Form CORRESP - Correspondence
2023/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/26

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/04/28

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/02

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/06

重要事件披露

8-K - Current report
2022/10/27

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/11

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/11

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]